A randomized, controlled, open label non-inferiority trial of intravenous ferric carboxymaltose versus iron sucrose in patients with iron deficiency anemia in China

{{article.zuoZheEn}}

PDF(1582 KB)
PDF(1582 KB)
Front. Med. ›› 2024, Vol. 18 ›› Issue (1) : 98-108. DOI: 10.1007/s11684-023-1001-2
RESEARCH ARTICLE

A randomized, controlled, open label non-inferiority trial of intravenous ferric carboxymaltose versus iron sucrose in patients with iron deficiency anemia in China

  • {{article.zuoZheEn}}
Author information +
History +

Highlights

{{article.highlightEn}}

Abstract

{{article.abstractEn}}

Author summary

{{article.authorSummayEn}}

Keywords

Cite this article

EndNote

Ris (Procite)

Bibtex

Download citation ▾
{{article.zuoZheEn_L}}. {{article.titleEn}}. Front. Med., 2024, 18(1): 98‒108 https://doi.org/10.1007/s11684-023-1001-2

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

RIGHTS & PERMISSIONS

{{article.copyright.year}} {{article.copyright.holder}}
PDF(1582 KB)

Accesses

Citations

Detail
Sections
Recommended

/

〈 〉